The Irish Times

Open Orphan spin-out Poolbeg to raise £25m in IPO

Infectious diseases specialist to list in London

Wed Jul 14 2021 - 19:31

Luke O’Neill: ‘I would be in bits by now without music. It has held me together’

Soundtrack of My Life: The scientist on tracks that have helped him through the pandemic

Thu Mar 18 2021 - 06:00

Covidius horribilis: Business winners and losers of 2020

Coronavirus meant the end for many firms, while others adapted and prospered

Mon Dec 28 2020 - 05:43

Inflazome’s Matt Cooper named best emerging entrepreneur

Roche recently paid €380m for the company founded by Mr Cooper and Prof Luke O’Neill

Thu Nov 12 2020 - 20:25

Life Scientific founder Nicola Mitchell named entrepreneur of year

Agrochemicals company employs more than 70 people and generates €60m in revenue

Thu Nov 12 2020 - 19:56

Fountain closes third life sciences fund after raising €125m

Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors

Tue Nov 03 2020 - 11:53

Irish leukaemia drug firm Priothera raises €30m to develop therapy

Key players in Dublin-based start-up were involved in successful Inflazome venture

Mon Oct 12 2020 - 11:31

Prof Matt Cooper: ‘it’s not about the money; it’s about the patients’

Inflazome, company he founded with Luke O’Neill, sold to Roche for an initial €380m

Wed Sept 30 2020 - 05:00

Year to remember for Fountain Healthcare Partners

Cantillon: Venture capital business sells Inflazome to Roche for €380m

Tue Sept 22 2020 - 05:35

Swiss drug giant Roche pays €380m for Irish biotech Inflazome

Company developing medicines for chronic inflammatory diseases such as Alzheimer’s

Mon Sept 21 2020 - 07:03

Inflazome secures orphan drug status for Inzomelid

Designation means it will be easier for Irish company to gain approval for therapy

Wed Jul 15 2020 - 08:37

Irish VC group Fountain Healthcare Partners raises €118m

Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Thu May 23 2019 - 20:21

Dublin start-up raises €15m to target inflammatory diseases

Inflazome has drug ready to enter human clinical trials

Mon Sept 12 2016 - 05:30